Business Context and Reporting Period
This Form 8-K Current Report was filed by Quantum-Si Incorporated (QSI) on September 21, 2023, covering events occurring on September 15, 2023. The filing primarily addresses corporate governance changes, specifically the appointment of a new director and a committee chairperson.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on personnel and governance updates.
Material Changes
- Board Expansion: The Board of Directors increased its size from eight to nine members.
- New Director Appointment: Amir Jafri was appointed to the Board, effective September 22, 2023. He is an independent director with extensive experience in healthcare and medical device operations.
- Committee Leadership: John Patrick ("Jack") Kenny was appointed as Chairperson of the Nominating and Corporate Governance Committee.
Outlook, Risks, and Management Commentary
Management highlighted Mr. Jafri's qualifications, noting his background as the founder and CEO of Immunicom, Inc., and his prior executive roles at Cardinal Health and West Health Institute. The Board determined Mr. Jafri is independent under Nasdaq listing rules. No new risks, contingencies, or unusual items were disclosed in this report. Mr. Jafri will receive standard nonemployee director compensation and will enter into a standard indemnification agreement.
Key Facts for Investor Verification
- Verify the effective date of Amir Jafri's board service (September 22, 2023).
- Confirm the total number of board members is now nine.
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.
- Note that no financial performance data is included in this specific filing.